Is Flamel Technologies S.A. (ADR) (FLML) A Good Stock To Buy?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Posts Tagged ‘NASDAQ:FLML’
Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capital’s Investment Moves?
At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on.
One REIT and Three Healthcare Companies See Insiders Buying and Selling Stock
The main indices on the US stock market are gaining ground on Tuesday, recovering from yesterday's declines as markets across the world are in the green.
The Most Popular French Stocks Among Hedge Funds
French president François Hollande was recently quoted as saying “ça va mieux” of his country's economy, which means that things are improving.
Two Healthcare Companies and One Micro-Cap Company Register Strong Insider Buying
Piggybacking insider trading has been a profitable investment strategy over the past several decades or so based on research, though new regulations and an increased use of stock...
A Look At Smart Money Three Latest Moves
In new filings with the U.S. Securities and Exchange Commission, Kelly Cardwell’s Central Square Management, James E.
A Look At Four Stocks Down In Last Trading Session of 2015
With the S&P 500 down today and risking to close the last trading day of 2015 in the red, a number of stocks have slipped significantly below the market.
A Look at Top Picks of This Billion-Dollar Healthcare-Focused Fund
Deerfield Management, a healthcare-focused fund managed by James E.
Hedge Funds Are Dumping Flamel Technologies S.A. (ADR) (FLML)
We, at Insider Monkey, have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Broadfin Capital Discloses New Stake in This Canadian Biotechnology Company
Broadfin Capital, led by Kevin Kotler, has initiated a new position in QLT Inc. (USA) (NASDAQ:QLTI). In a new filing with the U.S.
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler's Broadfin Capital has initiated a stake in ContraFect Corp (NASDAQ:CFRX) to the...
Apple Inc. (AAPL), Flamel Technologies S.A. (FLML), and Johnson & Johnson (JNJ): Bailard’s Top Q2 Picks
In a new 13F filing with the U.S. Securities and Exchange Commission, Bailard Inc, managed by Thomas Bailard, has revealed its equity portfolio held as of March 31.
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross understatement.
Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains
Kevin Kotler's Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).
Biotech Hedge Fund Deerfield Management’s Top Stock Picks
James E. Flynn's Deerfield Management is one of the funds that is focused on the healthcare sector, investing around 70% of its portfolio in healthcare stocks.
This Metric Says You Are Smart to Buy Petmed Express Inc (PETS)
In the 21st century investor’s toolkit, there are a multitude of metrics market participants can use to analyze stocks.
